Below, the results of our studies demonstrate that inhibition of the JNK pathway is able to down-regulate ABCG2 and the JNK pathway can be exploited for overcoming ABCG2-mediated multidrug resistance in colon cancer. Here, ABCG2 is linked to malignant colon neoplasm.